GLP-2
GLP2T is a dual GIP (Glucose-dependent insulinotropic polypeptide) and GLP-1 (Glucagon-like peptide-1) receptor agonist. In laboratory research, it is used to quantify the synergistic effects of incretin mimetics on insulin secretion and gastric emptying rates. Research focuses on its capacity to regulate glucose metabolism and its systemic influence on adipose tissue reduction in various experimental models.
- Intestinal Growth: Stimulates the growth of mucosal cells to expand the surface area of the gut.
- Barrier Function: Strengthens the intestinal wall to protect against damage and leaky gut.
- Common Issues: Stomach pain, bloating, nausea, vomiting, and swelling in the hands or feet.
- Severe Risks: Possible bowel blockage, gallbladder or pancreas swelling, or growth of small polyps in the gut.











Reviews
There are no reviews yet.